Search for: "Ocean Industries v. Greene" Results 41 - 60 of 76
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design field… [read post]
13 Aug 2019, 1:14 pm by Jim Walker
Plastic pollution in the ocean is of epidemic proportion and has the potential to threaten the health of the oceans, coral reefs, food safety and tourism. [read post]
18 Jul 2008, 8:34 am
: (GenericsWeb), Eularis analyses most effective generics defence strategies with new pharmaceutical industry report: (GenericsWeb), WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), Daiichi Sankyo and Ranbaxy confirm deal is binding and final, allay market rumour and speculation: (SmartBrief), Daiichi Ranbaxy takeover and the implications for the future of IP: (Spicy IP), Europe: Cancer Research Therapeutics’ RNAi patent revoked by… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its… [read post]
2 May 2008, 7:00 am
, India: Mint story on patent loophole in India regarding the importation of generics: (Spicy IP), India: WHO lambasts Indian drug regulatory system: (Spicy IP), India: Minister to ensure that reduced excise duty to reflect in drug prices: (Spicy IP), India: SCC journal article ‘Intellectual property rights and the challenges faced by the pharmaceutical industry’: (Spicy IP), Poland: Trade marks for medicines: (Class 46), US: IPO publishes letter… [read post]
31 Oct 2009, 4:06 pm by admin
— EPA News Release, October 26, 2009 Cytec Industries, an international chemical company based in Wallingford, Conn., will pay a civil penalty of $155,000 and spend $150,000 to perform an environmentally beneficial project to resolve EPA claims that the company violated the federal Clean Air Act. [read post]
9 May 2008, 10:30 pm
: (Ezine @rticles) Global - Patents Rise of machine translation services: (IPKat), USPTO / EPO / JPO progress on ‘common application format’ for expedited examination: (Peter Zura's 271 Patent Blog), Proponents: ‘Time is now’ for TRIPs biodiversity amendment in Doha round: (Intellectual Property Watch), TRIPs amendment in favour of disclosures for genetic resources/traditional knowledge patents gathers support: (Afro-IP), WIPO… [read post]
9 Sep 2013, 10:03 pm by Daniel B. Cohen
They tested both for specific human pathogens, such as Salmonella and O157:H7 E. coli, and for generic E. coli, which is required for members of the California Leafy Green Handlers Marketing Agreement (CA LGMA). [read post]
5 Jul 2008, 11:05 am
’: (IP finance), Allied Security Trust – High-tech companies pool resources to fight trolls: (IAM), (Techdirt), (Patent Prospector), (Ars Technica), (Technological Innovation and Intellectual Property) Global - Copyright On distinguishing between creative commons, the public domain, and all rights reserved – confusion in mainstream media: (creativecommons.org), Inside views: a new business model for the music industry explained: (Intellectual Property Watch),… [read post]
7 Apr 2010, 3:44 pm by admin
SETTLEMENTS EPA to Allow States Address Rising Ocean Acidity. [read post]
6 Feb 2018, 7:24 am
Building infrastructure across Eurasia would also have the double advantage of helping to get rid of some of China’s excess industrial capacity that had been created by the 2008 stimulus package, while further supporting the state conglomerates’ “going global” strategy. [read post]